Talking Euretina

Uveal melanoma remains a significant challenge, with genetic alterations playing a crucial role in treatment decisions. In this episode, Prof Jens Folke Kiilgaard (Denmark) and Dr Emine Kilic (Netherlands) join Prof Antonia Joussen (Germany) to explore why metastases persist despite primary tumor treatment, the limitations of checkpoint inhibitors, and the latest on Tebentafusp and Darovasertib. W...

In this episode, Chair Alistair Laidlaw (UK) chats to Mario Romano (Italy) and Stratos Gotzaridis (Greece) about some of the considerations and complications surrounding the use of intraocular tamponades. They also discuss the upcoming Special Focus Meeting in Athens which will centre on vitreoretinal surgery (VR)

In this final episode of highlights from the Barcelona congress 2024, we’ll hear from Dr Arshad Khanani (USA) about clinical trials, long term-data and the importance of personalising the treatment to the patient

In this second episode looking at highlights from the Barcelona congress, we'll hear about AI and sustainability in ophthalmology from Prof Jean-Francois Korobelnik of University Hospital Bordeaux

Barcelona, We love you! Over the next few episodes, we'll be hearing from 3 different sub-specialty experts about their favourite picks from the excellent Euretina Congress this year. This week, we hear from Ms. Rumana Hussain, Consultant Ophthalmologist specialising in Ocular Oncology and VR surgery at Liverpool University Trust Foundation Hospitals

In this episode, Prof Nicole Eter (Germany) speaks with Dr Yousif Subhi, this year's Ophthalmologica lecture about his work in meta-analyses, evidence synthesis, determination of best-practice, and clinical research

In this episode, Professor Kyoko Ohno-Matsui discusses advancements in imaging technologies and the management of myopic maculopathy ahead of her keynote lecture at the upcoming Euretina Congress in Barcelona. Chaired by Euretina President, Professor Anat Loewenstein

Ahead of his prestigious Gisbert Richard lecture at this year's upcoming Euretina congress in Barcelona, David Yorston speaks to Euretina board member and former president Mr Alistair Laidlaw about his impressive career highlights and what we have learned so far from the BEAVRS Database

In this episode, Drs Kristina Pfau (Switzerland) and Elon Van Dijk (Netherlands) will talk about the importance of the YOURS committee, representing young retina specialists across Europe. They'll also discuss the opportunities that lie ahead and the challenges that are faced by early career clinicians and researchers

In this podcast, Prof Frank Holz (Germany) discusses assessment of visual dysfunction in Intermediate AMD in the context of the Macustar trial with Dr Hannah Dunbar, Principal Optometrist at Moorfields and UCL

In this podcast, Bart Leroy and Mark Pennesi discuss a provocative paper in Cell that seems to draw a link between bacteria normally found in our gut and retinal diseases such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). This episode was an initiative of EURETINA in collaboration with ERN-EYE (European Reference Network for Rare Eye Disease). 

In this episode, Zohar Habot-Wilner (Israel) and Elisabetta Miserocchi (Italy) explore the key elements of clinical examination and how to approach work up when treating patients presenting with Uveitis. The discussion is chaired by Bahram Bodhagi (France)

In this episode, something a little different from the world of basic science: an interview with Bob J Johnston of Johns Hopkins who has been working with retinal organoids for the past decade. How are they made? What does industry think of them and will they one day become the default paradigm for retinal clinical research? Chaired by Jonathan McCrea

In this episode, we hear from an expert panel as they delve into the critical topic of second eye risk of retinal detachment (RD) and discuss approaches to prophylaxis. With Alistair Laidlaw (UK), Patricia Udaondo (Spain) and David Steel (UK)

Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes

In this podcast episode, we will dig into the subject of radiation maculopathy, the most common complication following the irradiation of intraocular tumours, with a panel of ocular oncologists from across Europe: Hibba Quhill (UK), Iwona Rospond-Kubiak (Poland), Emine Kilic (Netherlands) and Raffaele Parrozzani (Italy).

In this episode we look at two very interesting papers published in the latest editions of Ophthalmologica - Martin Busch presents his work on using microRNA as biomarkers for retinal disease and the panel discuss Christina Weisheit 's paper on Co2 emissions from the ophthalmic OR. Chaired by Patricia Udaondo, Matias Iglicki and Andreas Ebneter.   Links to papers:  https://karger.com/oph/article/2...

Fresh from his exciting win of the Lasker Award - often dubbed the American Nobel Prize - Professor David Huang (USA) - the inventor of optical coherence tomography (OCT) - joins Prof Pearse Keane (UK) and Tunde Peto (Hungary/UK) to talk about how he and colleagues developed the technology and about the impact it has had on retinal medicine

As applications open for the Euretina Retinal Medicine Clinical Research Award, we hear about the award from Euretina EVP, Dara Conlon. We also gain interesting insights from previous winners Camiel Boon (Netherlands) and João Pedro Marques (Portugal) to see how the award has furthered their research.

In this podcast Euretina President, Mr Alistair Laidlaw and Euretina EVP Dara Conlon explore the highlights of this year's congress which is on track to be the biggest and most exciting meeting yet!

In this episode, journalist Ramadan Younis and his executive producer Simon Cox tell us about their far-reaching BBC documentary. "Blind Faith" exposes the international practice of defrauding patients of Retinitis Pigmentosa with false hopes of treatment or cure with little or no evidence of efficacy. They are joined by Prof Robert McLaren of the University of Oxford, who consulted on the documen...

In this episode, we’re going to dig into the subject of this year’s Ophtalmologica lecture which will be delivered on the Saturday afternoon at this year’s congress in Amsterdam. Professor Maximilan Pfau is a clinician with a specialism in AMD and Inherited Retinal diseases in the Department of Ophthalmology at the University Eye Hospital, Basel, Switzerland. He's joined by Editor in Chief of the...

In this episode, we head to Asia to hear from colleagues in Japan, Singapore and South Korea about their experiences treating PCV and Pachychoroid in different populations. The podcast is chaired by Prof Taiji Sakamoto (Japan) and Prof SeungYoung Yu (South Korea) who are joined by Prof Gemmy Cheung and Prof Adrian Koh (Singapore)

In this podcast, we hear from Euretina Keynote Bertil Damato (UK/Sweden) about his upcoming talk on OncoVR at the 2023 Euretina Congress. He is joined by colleague Carl Groenewald (UK) and Heinrich Heimann (Chair - UK)

In this podcast, we'll be hearing about an exciting new event taking place in Amsterdam at the Euretina Congress in October; the inaugural Euretina Innovation Summit (EIS). Kourous Rezaei (USA) and Anat Loewenstein (Israel) - two members of the organising committee - will discuss the programme and motivation behind the event with chair Frank G Holz (Germany)